AmerisourceBergen Corp.  

(Public, NYSE:ABC)   Watch this stock  
Find more results for ABC
76.79
-0.39 (-0.51%)
Sep 23 - Close
NYSE real-time data - Disclaimer
Currency in USD
Range 76.43 - 77.15
52 week 60.69 - 79.13
Open 76.72
Vol / Avg. 1.20M/1.11M
Mkt cap 17.32B
P/E 68.41
Div/yield 0.23/1.22
EPS 1.12
Shares 224.38M
Beta 0.67
Inst. own 86%
Oct 29, 2014
Q4 2014 AmerisourceBergen Corp Earnings Release (Estimated) - 9:30AM EDT - Add to calendar
Sep 10, 2014
AmerisourceBergen Corp at Morgan Stanley Healthcare Conference - Webcast
Jul 24, 2014
Q3 2014 AmerisourceBergen Corp Earnings Call - Webcast
Jul 24, 2014
Q3 2014 AmerisourceBergen Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Jun '14) 2013
Net profit margin -0.04% 0.56%
Operating margin 0.26% 1.02%
EBITD margin - 1.27%
Return on average assets -0.25% 2.87%
Return on average equity -2.48% 20.67%
Employees 12,000 -
CDP Score - -

Address

Suite 100, 1300 Morris Drive
CHESTERBROOK, PA 19087
United States - Map
+1-610-7277000 (Phone)
+1-610-6470141 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
About Company - Wikipedia

Description

AmerisourceBergen Corporation (AmerisourceBergenis) is a pharmaceutical services company serving the United States, Canada and select global markets. The Company distributes a range of pharmaceuticalsgeneric pharmaceuticals, over-the-counter healthcare products, home healthcare supplies and equipment, and related services to a range of healthcare providers located in the United States, Canada and selected global markets, including acute care hospitals and health systems, independent and chain retail pharmacies, mail order pharmacies, medical and dialysis clinics, physicians and physician group practices, long-term care and other alternate site pharmacies, and other customers. In May 2013, the Company completed the divestiture of its contract packaging business, AndersonBrecon. In June 2013, the Company announced that has completed the divestiture of AmerisourceBergen Canada Corporation (ABCC).

Officers and directors

Richard C. Gozon Independent Chairman of the Board
Age: 75
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Steven H. Collis President, Chief Executive Officer, Director
Age: 52
Bio & Compensation  - Reuters
Trading Activity - Yahoo Finance
Tim G. Guttman Chief Financial Officer, Senior Vice President
Age: 54
Bio & Compensation  - Reuters
John G. Chou Executive Vice President, General Counsel
Age: 57
Bio & Compensation  - Reuters
June Barry Senior Vice President - Human Resources
Age: 62
Bio & Compensation  - Reuters
James D. Frary Senior Vice President and President - AmerisourceBergen Specialty Distribution and Services
Age: 41
Bio & Compensation  - Reuters
Peyton R. Howell Senior Vice President, President - Global Sourcing and Manufacturer Relations
Age: 46
Bio & Compensation  - Reuters
David W. Neu Senior Vice President and President of AmerisourceBergen Drug Corporation
Age: 56
Bio & Compensation  - Reuters
Gregory D. Wasson Director
Age: 55
Bio & Compensation  - Reuters
Douglas R. Conant Independent Director
Age: 62
Bio & Compensation  - Reuters